- Home
- CVBF vs SLNO Comparison
CVBF vs SLNO Comparison
Compare CVBF & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CVBF | SLNO |
|---|---|---|
| Founded | 1974 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.3B |
| IPO Year | 2009 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CVBF | SLNO |
|---|---|---|
| Price | $18.98 | $30.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | $24.17 | ★ $105.27 |
| AVG Volume (30 Days) | 1.2M | ★ 1.5M |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.14% | N/A |
| EPS Growth | 5.56 | ★ 108.90 |
| EPS | ★ 1.52 | 0.39 |
| Revenue | N/A | ★ $1,450,788.00 |
| Revenue This Year | $21.47 | $150.65 |
| Revenue Next Year | $15.21 | $56.10 |
| P/E Ratio | ★ $12.72 | $81.72 |
| Revenue Growth | N/A | ★ 138.82 |
| 52 Week Low | $16.01 | $30.11 |
| 52 Week High | $21.48 | $89.12 |
Technical Indicators
Market Signals| Indicator | CVBF | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 45.08 | 27.96 |
| Support Level | $18.18 | N/A |
| Resistance Level | $19.41 | $41.48 |
| Average True Range (ATR) | 0.46 | 1.85 |
| MACD | 0.07 | -0.35 |
| Stochastic Oscillator | 51.41 | 5.83 |
Price Performance
Historical ComparisonAbout CVBF CVB Financial Corporation
CVB Financial Corp is the holding company for Citizens Business Bank. Citizens Business Bank offers banking, lending, and investing services. It provides a full complement of lending products, including commercial, agribusiness, consumer, SBA, real estate, and construction loans, as well as equipment and vehicle leasing. Commercial products include lines of credit and other working capital financing, accounts receivable lending and letters of credit.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.